229 related articles for article (PubMed ID: 32614834)
1. Poor oral health conditions and cognitive decline: Studies in humans and rats.
Zhang S; Yang F; Wang Z; Qian X; Ji Y; Gong L; Ge S; Yan F
PLoS One; 2020; 15(7):e0234659. PubMed ID: 32614834
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
[TBL] [Abstract][Full Text] [Related]
3. [Association between periodontitis and mild cognitive impairment: a clinical pilot study].
Lin ZK; Ma SJ; Qian JL; Lin SH; Xia YR; Xie YF; Wang HY; Shu R
Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Jun; 57(6):576-584. PubMed ID: 35692001
[No Abstract] [Full Text] [Related]
4. Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice.
Garcez ML; Mina F; Bellettini-Santos T; Carneiro FG; Luz AP; Schiavo GL; Andrighetti MS; Scheid MG; Bolfe RP; Budni J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():23-31. PubMed ID: 28336494
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and cognitive effects of interferon-β1a (IFNβ1a) in a rat model of Alzheimer's disease.
Mudò G; Frinchi M; Nuzzo D; Scaduto P; Plescia F; Massenti MF; Di Carlo M; Cannizzaro C; Cassata G; Cicero L; Ruscica M; Belluardo N; Grimaldi LM
J Neuroinflammation; 2019 Feb; 16(1):44. PubMed ID: 30777084
[TBL] [Abstract][Full Text] [Related]
6. Association between Periodontal Health Status and Cognitive Abilities. The Role of Cytokine Profile and Systemic Inflammation.
Sochocka M; Sobczyński M; Sender-Janeczek A; Zwolińska K; Błachowicz O; Tomczyk T; Ziętek M; Leszek J
Curr Alzheimer Res; 2017; 14(9):978-990. PubMed ID: 28317488
[TBL] [Abstract][Full Text] [Related]
7. Cross-sectional associations of oral health measures with cognitive function in late middle-aged adults: a community-based study.
Naorungroj S; Schoenbach VJ; Beck J; Mosley TH; Gottesman RF; Alonso A; Heiss G; Slade GD
J Am Dent Assoc; 2013 Dec; 144(12):1362-71. PubMed ID: 24282266
[TBL] [Abstract][Full Text] [Related]
8. Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
Cestari JA; Fabri GM; Kalil J; Nitrini R; Jacob-Filho W; de Siqueira JT; Siqueira SR
J Alzheimers Dis; 2016 Apr; 52(4):1479-85. PubMed ID: 27104907
[TBL] [Abstract][Full Text] [Related]
9. Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.
Baluchnejadmojarad T; Mohamadi-Zarch SM; Roghani M
Metab Brain Dis; 2019 Dec; 34(6):1747-1759. PubMed ID: 31422512
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ
Zhang X; Wang X; Hu X; Chu X; Li X; Han F
Phytomedicine; 2019 Apr; 57():331-338. PubMed ID: 30807987
[TBL] [Abstract][Full Text] [Related]
11. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
12. [Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease].
Li W; Zhang JW; Lu F; Ma MM; Wang JQ; Suo AQ; Bai YY; Liu HQ
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(39):2743-6. PubMed ID: 23290159
[TBL] [Abstract][Full Text] [Related]
13. Huannao Yicong Decoction () extract reduces inflammation and cell apoptosis in Aβ
Wang Q; Li H; Wang FX; Gao L; Qin JC; Liu JG; Wei Y; Liu MX
Chin J Integr Med; 2017 Sep; 23(9):672-680. PubMed ID: 27022730
[TBL] [Abstract][Full Text] [Related]
14. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
15. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric Oxygen Pretreatment Improves Cognition and Reduces Hippocampal Damage Via p38 Mitogen-Activated Protein Kinase in a Rat Model.
Zhao B; Pan Y; Wang Z; Xu H; Song X
Yonsei Med J; 2017 Jan; 58(1):131-138. PubMed ID: 27873505
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Oral Health and Body Mass Index among Nepalese Teachers.
Shrestha S; Shrestha RM
Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):231-234. PubMed ID: 28814684
[TBL] [Abstract][Full Text] [Related]
18. Icariside II, a Phosphodiesterase-5 Inhibitor, Attenuates Beta-Amyloid-Induced Cognitive Deficits via BDNF/TrkB/CREB Signaling.
Liu S; Li X; Gao J; Liu Y; Shi J; Gong Q
Cell Physiol Biochem; 2018; 49(3):985. PubMed ID: 30196289
[TBL] [Abstract][Full Text] [Related]
19. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Cognitive Function, Oral Conditions and Systemic Metabolic Function in the Elderly.
Karako K; Chen Y; Oyama K; Hu L; Sakatani K
Adv Exp Med Biol; 2023; 1438():27-31. PubMed ID: 37845435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
